Abstract
Accurately diagnosing pediatric patients with specific epilepsy syndromes remains a major challenge today. The diagnosis of epilepsy syndrome is established on the basis of the age of onset, type of epilepsy, progressive nature of the disease, interictal EEG abnormalities, gender predominance, precipitating factors, family history, neuropsychological features and prognosis. A diagnosis of pediatric epilepsy syndrome can be complicated by a number of factors and the established diagnosis affects the treatment options. Further, pediatric epilepsy patients respond differently to various treatments making prognosis difficult. Epilepsy syndromes are further divided into generalized, focal, undetermined and “special” syndromes based on the Committee on Classification and Terminology of the International League Against Epilepsy (1989). In this chapter, we will discuss the major epileptic syndromes seen in childhood and adolescence, their salient clinical features, ictal and interictal EEG characteristics, prognosis and treatment options.
Keywords: Epilepsy syndromes, EEG, localization related epilepsies, generalized epilepsies, progressive myoclonic epilepsies
Current Pediatric Reviews
Title: Overview of Pediatric Epilepsy
Volume: 8 Issue: 1
Author(s): Batool F. Kirmani
Affiliation:
Keywords: Epilepsy syndromes, EEG, localization related epilepsies, generalized epilepsies, progressive myoclonic epilepsies
Abstract: Accurately diagnosing pediatric patients with specific epilepsy syndromes remains a major challenge today. The diagnosis of epilepsy syndrome is established on the basis of the age of onset, type of epilepsy, progressive nature of the disease, interictal EEG abnormalities, gender predominance, precipitating factors, family history, neuropsychological features and prognosis. A diagnosis of pediatric epilepsy syndrome can be complicated by a number of factors and the established diagnosis affects the treatment options. Further, pediatric epilepsy patients respond differently to various treatments making prognosis difficult. Epilepsy syndromes are further divided into generalized, focal, undetermined and “special” syndromes based on the Committee on Classification and Terminology of the International League Against Epilepsy (1989). In this chapter, we will discuss the major epileptic syndromes seen in childhood and adolescence, their salient clinical features, ictal and interictal EEG characteristics, prognosis and treatment options.
Export Options
About this article
Cite this article as:
F. Kirmani Batool, Overview of Pediatric Epilepsy, Current Pediatric Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339612799746399
DOI https://dx.doi.org/10.2174/157339612799746399 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pregabalin Dependence: A Case Report
Current Drug Safety Synthesis and Anticonvulsant Activity Evaluation of Some 1-alkoxy-4-(1H- 1,2,4-triazol-1-yl)phthalazines
Letters in Drug Design & Discovery Prediction of an Interaction between Bakuchiol and Acetylcholinesterase using Adaboost
Current Bioinformatics Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Regulation of Ion Channels, Cellular Carriers and Na(+)/K(+)/ATPase by Janus Kinase 3
Current Medicinal Chemistry Monocyclic and Fused Azines and Azoles as Histamine H<sub>4</sub> Receptor Ligands
Current Medicinal Chemistry Chronic Inflammatory Diseases: Progress and Prospect with Herbal Medicine
Current Pharmaceutical Design Cyclooxygenase and Neuroinflammation in Parkinsons Disease Neurodegeneration
Current Neuropharmacology Inflammatory Process in Parkinsons Disease: Role for Cytokines
Current Pharmaceutical Design Potential Therapeutic Relevance of Adenosine A2B and A2A Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry GABAB Receptors as Potential Therapeutic Targets
Current Drug Targets - CNS & Neurological Disorders The Combination of rTMS and Pharmacotherapy on In Vitro Models: A Mini-Review
CNS & Neurological Disorders - Drug Targets Antiepileptic Treatments in Developing Countries
Current Pharmaceutical Design Conantokins: Peptide Antagonists of NMDA Receptors
Current Medicinal Chemistry Green and Facile Reaction of Gabapentin with Sulfonyl Chlorides to Synthesize Lactams and Sulfonamides Derivatives in Aqueous Medium
Letters in Organic Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry Targeting Bacterial Metalloenzymes: A New Strategy for the Development of Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry Tandem Mass Spectrometry Newborn Screening for Inborn Errors of Intermediary Metabolism: Abnormal Profile Interpretation
Current Medicinal Chemistry